Evidence map›Paper›PMID 31435826›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2019

Functional analysis of isoprenoid precursors biosynthesis by quantitative metabolomics and isotopologue profiling.

Sara Castaño-Cerezo, Hanna Kulyk-Barbier, Pierre Millard, Jean-Charles Portais, Stéphanie Heux, Gilles Truan, Floriant Bellvert

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara Castaño-CerezoLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.ORCID 0000-0002-1404-4085
Hanna Kulyk-BarbierLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
Pierre MillardLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.ORCID 0000-0002-8136-9963
Jean-Charles PortaisLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
Stéphanie HeuxLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
Gilles TruanLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.ORCID 0000-0002-3560-8302
Floriant BellvertLISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France. bellvert@insa-toulouse.fr.ORCID 0000-0002-3259-8655

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIsoprenoids are amongst the most abundant and diverse biological molecules and are involved in a broad range of biological functions. Functional understanding of their biosynthesis is thus key in many fundamental and applicative fields, including systems biology, medicine and biotechnology. However, available methods do not yet allow accurate quantification and tracing of stable isotopes incorporation for all the isoprenoids precursors.

objectivesWe developed and validated a complete methodology for quantitative metabolomics and isotopologue profiling of isoprenoid precursors in the yeast Saccharomyces cerevisiae.

methodsThis workflow covers all the experimental and computational steps from sample collection and preparation to data acquisition and processing. It also includes a novel quantification method based on liquid chromatography coupled to high-resolution mass spectrometry. Method validation followed the Metabolomics Standards Initiative guidelines.

resultsThis workflow ensures accurate absolute quantification (RSD < 20%) of all mevalonate and prenyl pyrophosphates intermediates with a high sensitivity over a large linear range (from 0.1 to 50 pmol). In addition, we demonstrate that this workflow brings crucial information to design more efficient phytoene producers. Results indicate stable turnover rates of prenyl pyrophosphate intermediates in the constructed strains and provide quantitative information on the change of the biosynthetic flux of phytoene precursors.

conclusionThis methodology fills one of the last technical gaps for functional studies of isoprenoids biosynthesis and should be applicable to other eukaryotic and prokaryotic (micro)organisms after adaptation of some organism-dependent steps. This methodology also opens the way to

Indexed as

DiphosphatesGas Chromatography-Mass SpectrometryMetabolomeMetabolomicsMevalonic AcidNeopreneSaccharomyces cerevisiaeTerpenesDiphosphatesMevalonic AcidNeopreneprenylTerpenesIsoprenoidsIsotope labeling experimentsMass spectrometrySystems biology

Identifiers

PMID31435826
PMCPMC6704079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.